An open randomised clinical trial involving Haloperidol, Olanzapine, Quetiapine, Risperidone, and Ziprasidone in first episode never-treated psychosis

Phase 4

Completed

• Conditions: Antipsychotic discontinuation in first episode psychosis; Mental Health - Schizophrenia; Mental Health - Psychosis and personality disorders; Mental Health - Other mental health disorders

• Registration Number: ACTRN12610000954022
• Lead Sponsor: illy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-11-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Showing psychotic symptoms at admission (having a score of 4 or more on PANSS positive scale items 1, 3, 5, or 6) and being naive of antipsychotic, antidepressant or mood stabilizer treatment.

Signing a consent document

Exclusion Criteria

Presence of a major medical or neurological disease, mental retardation, suspicion of substance use directly contributing to the emergence of symptoms (not merely a comorbid condition) and previous treatment with psychotropic drugs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified